Maria Callejo
Madrid, MD 28040, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human.
Journal: Vascular pharmacology
Published: January 31, 2024
Vitamin D receptor and its antiproliferative effect in human pulmonary arterial hypertension.
Journal: Scientific reports
Published: August 16, 2023
Corrigendum: Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
Journal: Frontiers in pharmacology
Published: May 25, 2023
Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension.
Journal: Frontiers in pharmacology
Published: January 16, 2023
Cardiac and Pulmonary Vascular Dysfunction in Vitamin D-Deficient Bmpr2-Mutant Rats.
Journal: American journal of respiratory cell and molecular biology
Published: September 01, 2022
Impact of a TAK-1 inhibitor as a single or as an add-on therapy to riociguat on the metabolic reprograming and pulmonary hypertension in the SUGEN5416/hypoxia rat model.
Journal: Frontiers in pharmacology
Published: August 17, 2022
Vitamin D deficiency, a potential cause for insufficient response to sildenafil in pulmonary arterial hypertension.
Journal: The European respiratory journal
Published: April 27, 2021
Restoration of Vitamin D Levels Improves Endothelial Function and Increases TASK-Like K+ Currents in Pulmonary Arterial Hypertension Associated with Vitamin D Deficiency.
Journal: Biomolecules
Published: April 19, 2021
Oxygen-sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension.
Journal: Antioxidants (Basel, Switzerland)
Published: December 27, 2020
Uncovered Contribution of Kv7 Channels to Pulmonary Vascular Tone in Pulmonary Arterial Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: August 25, 2020
Hepatic Encephalopathy-Associated Cerebral Vasculopathy in Acute-on-Chronic Liver Failure: Alterations on Endothelial Factor Release and Influence on Cerebrovascular Function.
Journal: Frontiers in physiology
Published: August 10, 2020
Vitamin D deficiency downregulates TASK-1 channels and induces pulmonary vascular dysfunction.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: July 30, 2020
Last Updated: 09/26/2026